Anti-CXCL5 + CXCL6 抗体 [EP13083] - BSA and Azide free
Anti-CXCL5 + CXCL6 antibody [EP13083] - BSA and Azide free
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal CXCL5 antibody. Carrier free. Suitable for IP, WB, IHC-P and reacts with Human, Recombinant fragment - Human samples.
別名を表示する
ENA78, SCYB5, CXCL5, C-X-C motif chemokine 5, ENA-78(1-78), Epithelial-derived neutrophil-activating protein 78, Neutrophil-activating peptide ENA-78, Small-inducible cytokine B5, GCP2, SCYB6, CXCL6, C-X-C motif chemokine 6, Chemokine alpha 3, Granulocyte chemotactic protein 2, Small-inducible cytokine B6, CKA-3, GCP-2
- IP
Lab
Immunoprecipitation - Anti-CXCL5 + CXCL6 antibody [EP13083] - BSA and Azide free (AB284855)
This data was developed using ab198505, the same antibody clone in a different buffer formulation.
CXCL5 + CXCL6 was immunoprecipitated from 0.35 mg of A549 (Human lung carcinoma cell line) whole cell extract with ab198505 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab198505 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used as secondary antibody at 1/5000 dilution.
Lane 1 : A549 (Human lung carcinoma epithelial cell), whole cell lysate, 10µg
Lane 2 : A549 whole cell lysate with the ab198505 at 1/30 dilution
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab198505 in A549 whole cell lysate
All lanes:
Immunoprecipitation - Anti-CXCL5 + CXCL6 antibody [EP13083] (<a href='/products/primary-antibodies/cxcl5-cxcl6-antibody-ep13083-ab198505'>ab198505</a>) at 1/1000 dilution
All lanes:
A549 (Human lung carcinoma epithelial cell), whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 12 kDa
false
Exposure time: 93s
- WB
Lab
Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] - BSA and Azide free (AB284855)
This data was developed using ab198505, the same antibody clone in a different buffer formulation.
The expression of CXCL5 and CXCL6 is induced by TNF-a and PMA. (PMID 9057843; PMID : 23922745).
ab181602 was used a GAPDH loading control.
All lanes:
Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (<a href='/products/primary-antibodies/cxcl5-cxcl6-antibody-ep13083-ab198505'>ab198505</a>) at 1/10000 dilution
Lane 1:
A549 (Human lung carcinoma epithelial cell) starved overnight, whole cell lysate at 15 µg
Lane 2:
A549 (Human lung carcinoma epithelial cell) starved overnight, then treated with 10ng/ml TNF-a, 10nM TPA and 0.1% BSA for 24 hours, whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 12 kDa
false
Exposure time: 10s
- WB
Lab
Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] - BSA and Azide free (AB284855)
This data was developed using ab198505, the same antibody clone in a different buffer formulation.
The expression of CXCL5 and CXCL6 is induced by TNF-a and PMA. (PMID 9057843; PMID : 23922745).
ab181602 was used a GAPDH loading control.
All lanes:
Western blot - Anti-CXCL5 + CXCL6 antibody [EP13083] (<a href='/products/primary-antibodies/cxcl5-cxcl6-antibody-ep13083-ab198505'>ab198505</a>) at 1/10000 dilution
Lane 1:
HEK-293T cells transfected with an empty expression vector containing His tag, hole cell lysate
Lane 2:
HEK-293T cells transfected with a human CXCL5 expression vector containing His tag, then treated with 600 ng/ml BFA for 3h, whole cell lysate
Lane 3:
HEK-293T cells transfected with a human CXCL6 expression vector containing His tag, then treated with 600 ng/ml BFA for 3h, whole cell lysate
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 12 kDa
false
Exposure time: 10s
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-CXCL5 + CXCL6 antibody [EP13083]
Reactivity data
製品の詳細
ab284855 is the carrier-free version of ab198505
The production method for this product has been changed from hybridoma to recombinant on 15th April 2024.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
They coordinate immune response by mediating neutrophil recruitment to inflammatory sites. CXCL5 and CXCL6 often work as a team binding CXCR2 and aiding in protective tissue responses. Their roles extend further as they partake in triggering angiogenesis the formation of new blood vessels under physiological or pathological conditions such as wound healing or cancer. These activities imply their involvement in complex cellular networks and interactions.
Pathways
The involvement of CXCL5 and CXCL6 arises prominently in the NF-kB pathway and the MAPK signaling pathway. These pathways integral to immune and inflammatory responses reflect the chemokines' interaction with proteins like IL-8 and TNF-alpha emphasizing their importance in host defense mechanisms and inflammatory signaling cascades. Their ability to engage with these pathways demonstrates an essential role in modulating the intensity and duration of inflammatory responses.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
追加のターゲット
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com